Gene test to predict breast cancer recurrence less cost effective in real world practice
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
Jan 8, 2018
0
14